SLC15A4 controls endolysosomal TLR7-9 responses by recruiting the innate immune adaptor TASL
暂无分享,去创建一个
H. Eibel | Haobo Zhang | M. Rebsamen | Léa Bernaleau | Maeva Delacrétaz | Ed Hasanovic | Manuele Rebsamen | Haobo Zhang
[1] C. López-Haber,et al. The phagosomal solute transporter SLC15A4 promotes inflammasome activity via mTORC1 signaling and autophagy restraint in dendritic cells , 2022, The EMBO journal.
[2] T. Andrews,et al. TLR7 gain-of-function genetic variation causes human lupus , 2022, Nature.
[3] B. Beutler,et al. The solute carrier SLC15A4 is required for optimal trafficking of nucleic acid–sensing TLRs and ligands to endolysosomes , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[4] Y. Crow,et al. The type I interferonopathies: 10 years on , 2021, Nature Reviews Immunology.
[5] Toshihiko Kobayashi,et al. Lysosomal amino acid transporters as key players in inflammatory diseases. , 2021, International immunology.
[6] M. Suematsu,et al. SLC15A4 mediates M1-prone metabolic shifts in macrophages and guards immune cells from metabolic stress , 2021, Proceedings of the National Academy of Sciences.
[7] T. Taniguchi,et al. Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease , 2021, Nature Communications.
[8] G. Barton,et al. Regulation of the nucleic acid-sensing Toll-like receptors , 2021, Nature reviews. Immunology.
[9] G. Superti-Furga,et al. Recent developments in ligands and chemical probes targeting solute carrier transporters. , 2021, Current opinion in chemical biology.
[10] Toshihiko Kobayashi,et al. Human SLC15A4 is crucial for TLR-mediated type I Interferon production and mitochondrial integrity. , 2021, International immunology.
[11] Z. Modrušan,et al. The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models , 2021, PloS one.
[12] T. Dörner,et al. Toll-like receptor signalling in B cells during systemic lupus erythematosus , 2020, Nature Reviews Rheumatology.
[13] M. Weirauch,et al. Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus , 2020, Annals of the Rheumatic Diseases.
[14] G. Hartmann,et al. Immune Sensing Mechanisms that Discriminate Self from Altered Self and Foreign Nucleic Acids , 2020, Immunity.
[15] G. Superti-Furga,et al. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9 , 2020, Nature.
[16] K. Fitzgerald,et al. Toll-like Receptors and the Control of Immunity , 2020, Cell.
[17] L. Gallo,et al. The Druggability of Solute Carriers. , 2019, Journal of medicinal chemistry.
[18] W. Robinson,et al. B cell checkpoints in autoimmune rheumatic diseases , 2019, Nature Reviews Rheumatology.
[19] Zhijian J. Chen,et al. cGAS in action: Expanding roles in immunity and inflammation , 2019, Science.
[20] G. Núñez,et al. SLC15A2 and SLC15A4 Mediate the Transport of Bacterially Derived Di/Tripeptides To Enhance the Nucleotide-Binding Oligomerization Domain–Dependent Immune Response in Mouse Bone Marrow–Derived Macrophages , 2018, The Journal of Immunology.
[21] B. Beutler,et al. Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN , 2017, The Journal of Immunology.
[22] H. Tsutsui,et al. Lysosome biogenesis regulated by the amino-acid transporter SLC15A4 is critical for functional integrity of mast cells , 2017, International immunology.
[23] K. Nakayama,et al. Structural basis for the assembly of the Ragulator-Rag GTPase complex , 2017, Nature Communications.
[24] H. Lindner,et al. Crystal structure of the human lysosomal mTORC1 scaffold complex and its impact on signaling , 2017, Science.
[25] S. Newstead. Recent advances in understanding proton coupled peptide transport via the POT family. , 2017, Current opinion in structural biology.
[26] P. Gregersen,et al. Transancestral mapping and genetic load in systemic lupus erythematosus , 2017, Nature Communications.
[27] G. Diallinas. Transceptors as a functional link of transporters and receptors , 2017, Microbial cell.
[28] R. Keep,et al. A novel role for PHT1 in the disposition of l‐histidine in brain: In vitro slice and in vivo pharmacokinetic studies in wildtype and Pht1 null mice , 2017, Biochemical pharmacology.
[29] Kathleen E. Sullivan,et al. New insights into the immunopathogenesis of systemic lupus erythematosus , 2016, Nature Reviews Rheumatology.
[30] E. Latz,et al. Nucleic acid‐sensing TLRs and autoimmunity: novel insights from structural and cell biology , 2016, Immunological reviews.
[31] J. Rioux,et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus , 2015, Nature Genetics.
[32] Liwei Lu,et al. Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus , 2015, International journal of molecular sciences.
[33] Sky W. Brubaker,et al. Innate immune pattern recognition: a cell biological perspective. , 2015, Annual review of immunology.
[34] N. Grishin,et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation , 2015, Science.
[35] B. Beutler,et al. Slc15a4 function is required for intact class switch recombination to IgG2c in response to TLR9 stimulation , 2015, Immunology and cell biology.
[36] G. Superti-Furga,et al. SLC38A9 is a component of the lysosomal amino acid-sensing machinery that controls mTORC1 , 2014, Nature.
[37] S. Yokoyama,et al. The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. , 2014, Immunity.
[38] Anne-Kathrin Kienzler,et al. Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis. , 2014, The Journal of allergy and clinical immunology.
[39] R. Bonegio,et al. Interferon Regulatory Factor-5 Deficiency Ameliorates Disease Severity in the MRL/lpr Mouse Model of Lupus in the Absence of a Mutation in DOCK2 , 2014, PloS one.
[40] Zhaoshi Jiang,et al. Endosomes are specialized platforms for bacterial sensing and NOD2 signalling , 2014, Nature.
[41] H. Shin,et al. Ethnic specificity of lupus-associated loci identified in a genome-wide association study in Korean women , 2013, Annals of the rheumatic diseases.
[42] B. Beutler,et al. Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus , 2013, Proceedings of the National Academy of Sciences.
[43] J. Kere,et al. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations , 2012, European Journal of Human Genetics.
[44] P. Krebs,et al. Slc15a4, a Gene Required for pDC Sensing of TLR Ligands, Is Required to Control Persistent Viral Infection , 2012, PLoS pathogens.
[45] Lisong Yang,et al. Irf5‐deficient mice are protected from pristane‐induced lupus via increased Th2 cytokines and altered IgG class switching , 2012, European journal of immunology.
[46] N. Kato,et al. The solute carrier family 15A4 regulates TLR9 and NOD1 functions in the innate immune system and promotes colitis in mice. , 2011, Gastroenterology.
[47] T. Mak,et al. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. , 2011, Arthritis and rheumatism.
[48] B. Beutler,et al. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells , 2010, Proceedings of the National Academy of Sciences.
[49] K. Honda,et al. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus , 2010, Proceedings of the National Academy of Sciences.
[50] C. Liu,et al. IFN Regulatory Factor 5 Is Required for Disease Development in the FcγRIIB−/−Yaa and FcγRIIB−/− Mouse Models of Systemic Lupus Erythematosus , 2009, The Journal of Immunology.
[51] Ying Wang,et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus , 2009, Nature Genetics.
[52] D. Philpott,et al. pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling* , 2009, The Journal of Biological Chemistry.
[53] M. Okada,et al. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK–ERK pathway to late endosomes , 2009, The EMBO journal.
[54] M. Clare-Salzler,et al. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases , 2009 .
[55] Marta E Alarcón-Riquelme,et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus , 2006, Nature Genetics.
[56] J. Kere,et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. , 2005, American journal of human genetics.
[57] M. Tomonaga,et al. A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma , 2005, International journal of hematology.
[58] T. Yamashita,et al. Cloning and Functional Expression of a Brain Peptide/Histidine Transporter* , 1997, The Journal of Biological Chemistry.